Developer docs
API playgroundTry for free, no card

Search company profiles

InsituGen

Full company profile

uuid0003qu7

Namestring
InsituGen
Legal namestring
InsituGen Limited
Websiteurl
insitugen.com
Company typeenum
Private
Founded yearint
2020
Descriptiontext

InsituGen Limited is a New Zealand-based biotechnology company founded in 2020 that has commercialized a proprietary, multi-patented cell-free bioassay platform for the non-targeted detection of steroid hormone (androgen and estrogen) bioactivity. The platform replicates natural biological signaling pathways of estrogen and androgen receptors in a cell-free format, eliminating the requirement for live cell culture and enabling detection of novel and designer steroid compounds that targeted mass spectrometry methods can miss. Results are delivered in approximately two hours using standard laboratory fluorometers.

The company's commercial product portfolio comprises firstFlagX (FFX-1), a 96-well androgen bioactivity test kit marketed to equine anti-doping laboratories for screening samples from thoroughbred racehorses, racing camels, and human athletes; NeuterReady, a veterinary kit and service for assessing biological maturity to inform spay/neuter timing in companion animals; and a fee-for-service laboratory testing offering operated from the company's Dunedin, New Zealand facility. Named enterprise customers include Plasmaide (sports supplements), Biogold (pine pollen extracts), and Organic Initiative (organic feminine care), demonstrating traction in the supplement and natural-product testing segment.

InsituGen monetizes through one-time test kit sales and transaction-based laboratory testing services, with pricing set on a quote basis by volume and customer type. Go-to-market combines an exclusive worldwide distribution partnership with Berlinger Special AG (channel coverage into 175+ countries for firstFlagX in the equine anti-doping segment) with direct enterprise sales for NeuterReady and contract testing. The company is privately held, has between 11 and 50 employees, has raised approximately US$2.5 million in disclosed external capital since 2020 across NZ, US, and European investors, and is actively raising additional capital to support product development and commercial expansion.

Short descriptiontext

InsituGen Limited is a New Zealand biotech that sells cell-free bioassay test kits — firstFlagX for anti-doping laboratories and NeuterReady for companion animal maturity assessment — plus contract testing services, targeting anti-doping labs, veterinary clinics, and supplement manufacturers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCambridge, United Kingdom
HQ citystring
Cambridge
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cell-free bioassay, steroid hormone testing, anti-doping diagnostics, veterinary hormone assays, androgen bioactivity detection
Industry3 codes
PRIMARYHLAGADAH
Cell-Based & Potency Assays (Bioassays)
SECONDARYHLAMADAF
Reproductive & Endocrinology Diagnostics (Fertility, Hormones)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Diagnostics (Labs & Imaging)
SECONDARYHLAAAKAG
Analytical Testing & QC Release Services (potency, purity, sterility)
NAICS code2 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Medical and Diagnostic Laboratories62151
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Testing Laboratories8734
Product category
Bioassay Diagnostic Test Kits
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Test Kit Product Sales
TypeOne Time License
Description

Sale of proprietary test kits including firstFlagX and NeuterReady to laboratories, veterinary clinics, and anti-doping facilities. Revenue generated from initial kit purchases with recurring demand from ongoing testing requirements.

allaboutfeed.net
2Laboratory Testing Services
TypeTransaction Fee
Description

Contract testing services offered through InsituGen's New Zealand laboratory facility for samples requiring specialized bioactivity analysis. Provides fee-for-service revenue for complex or high-volume testing needs.

Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales
Pricing details1 tier
1Enterprise/B2B pricing for laboratory test kits
ModelOtherBilling cadencePay-as-you-go
Notes

Test kit pricing determined through direct quotation based on volume, customer type, and geographic location. No public price list available.

GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1firstFlagX
Description

InsituGen's bioassay technology transformed into a ready-to-use kit for the detection of total androgen bioactivity. Used in thoroughbred horse and camel anti-doping laboratories.

insitugen.com
+1 more record
Core offering1 text field

InsituGen develops and sells proprietary cell-free bioassay test kits for detecting androgen and estrogen steroid hormone bioactivity. The company offers the firstFlagX androgen bioactivity test kit for anti-doping laboratories, the NeuterReady veterinary test kit for companion animal hormone assessment, and contract testing services performed at its Dunedin, New Zealand laboratory.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Results delivered in 2 hours compared to 24-48 hours for traditional cell-based methods
+2 more records
Product overview1 text field

InsituGen offers a portfolio of bioassay-based products and services for steroid hormone detection. The core offering centers on cell-free bioassay technology that replicates natural biological signaling pathways of estrogen and androgen receptors. The main products are firstFlagX (an androgen bioactivity test kit for use in reference laboratories), NeuterReady (a veterinary testing service for companion animal maturity assessment), and a laboratory testing service for external customers. firstFlagX and NeuterReady are the two commercial products launched since the company's founding in 2020, with testing services providing additional customer access to the technology.

Product and service3 records
1firstFlagX Androgen Bioactivity Test Kit (FFX-1)
CategoryAnti-doping diagnostic kit
Description

A ready-to-use 96-well format bioassay kit that detects total androgen bioactivity, including unknown androgens, designer steroids, testosterone-mimics, and any compound that binds to the androgen receptor. Delivers results within 2 hours using standard laboratory fluorometers. Used by reference and anti-doping laboratories.

2NeuterReady
CategoryVeterinary diagnostic kit
Description

Veterinary testing service and kit for determining optimal timing for neutering/spaying companion animals based on biological maturity assessment through circulating androgen bioactivity, enabling data-driven treatment decisions. Used by veterinary clinics and companion animal owners.

3Testing Services – Test with Us
CategoryContract laboratory testing service
Description

Non-targeted testing service using InsituGen's cell-free bioassay technology at the New Zealand laboratory, testing human supplements, products, clinical plasma samples, and environmental samples for estrogen and androgen bioactivity.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Exclusive worldwide distribution partnership for firstFlagX androgen bioactivity test kits to equine anti-doping laboratories. Berlinger Special AG, a specialized provider of anti-doping equipment and services, distributes InsituGen's firstFlagX test kits globally, enabling market access to laboratories in over 175 countries. The partnership leverages Berlinger's established relationships with racing federations and anti-doping authorities.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Major analytical instrument provider (mass spec, chromatography) widely used in anti-doping reference laboratories. Represents the incumbent targeted-detection paradigm that InsituGen's non-targeted bioassay seeks to complement.

TypeBroad incumbent
Description

Leading veterinary diagnostics company serving companion animal clinics with in-clinic and reference lab testing. Comparable as a scaled veterinary diagnostics platform into which NeuterReady's hormone maturity test could be distributed.

TypeBroad incumbent
Description

Global testing, inspection, and certification company with dedicated supplement, food, and environmental contaminant testing services. Comparable as an established contract testing alternative for supplement and environmental bioactivity work.

TypeBroad incumbent
Description

Global analytical instruments and life sciences leader offering mass spectrometers, immunoassays, and clinical diagnostics that compete with and complement InsituGen's bioassay in anti-doping and clinical endocrinology reference labs.

TypeBroad incumbent
Description

Analytical instrument vendor (LC-MS/MS) used in equine and human anti-doping laboratories worldwide. Represents an alternative screening technology stack competing for the same lab budget.

TypeBroad incumbent
Description

Global testing services conglomerate with extensive anti-doping, supplement, and environmental testing capacity. Comparable as a large-scale service-lab competitor and potential channel partner for InsituGen's test kits.

TypeBroad incumbent
Description

Largest global animal health company with diagnostics and reproductive management products. Closely comparable as the dominant channel and R&D investor in companion animal diagnostics where NeuterReady competes.

TypeBroad incumbent
Description

Mass spectrometry platform vendor with deep penetration in anti-doping and clinical endocrinology reference labs. Competes for the same analytical workflow budget that InsituGen's firstFlagX targets.

TypeDirect peer
Description

Swiss anti-doping equipment specialist and exclusive worldwide distributor of InsituGen's firstFlagX kits. Operates in the same equine/human anti-doping laboratory customer segment and supplies complementary sample collection and cold-chain equipment used alongside bioassay testing.

TypeDirect peer
Description

Clinical and anti-doping diagnostics company offering biochip immunoassays and evidence-testing kits to sports, forensic, and clinical labs. Comparable as a multi-kit specialty diagnostics provider in anti-doping reference laboratories.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

InsituGen

Bioassay Diagnostic Test Kitsinsitugen.com

InsituGen Limited is a New Zealand biotech that sells cell-free bioassay test kits — firstFlagX for anti-doping laboratories and NeuterReady for companion animal maturity assessment — plus contract testing services, targeting anti-doping labs, veterinary clinics, and supplement manufacturers.

What InsituGen does

InsituGen Limited is a New Zealand-based biotechnology company founded in 2020 that has commercialized a proprietary, multi-patented cell-free bioassay platform for the non-targeted detection of steroid hormone (androgen and estrogen) bioactivity. The platform replicates natural biological signaling pathways of estrogen and androgen receptors in a cell-free format, eliminating the requirement for live cell culture and enabling detection of novel and designer steroid compounds that targeted mass spectrometry methods can miss. Results are delivered in approximately two hours using standard laboratory fluorometers.

The company's commercial product portfolio comprises firstFlagX (FFX-1), a 96-well androgen bioactivity test kit marketed to equine anti-doping laboratories for screening samples from thoroughbred racehorses, racing camels, and human athletes; NeuterReady, a veterinary kit and service for assessing biological maturity to inform spay/neuter timing in companion animals; and a fee-for-service laboratory testing offering operated from the company's Dunedin, New Zealand facility. Named enterprise customers include Plasmaide (sports supplements), Biogold (pine pollen extracts), and Organic Initiative (organic feminine care), demonstrating traction in the supplement and natural-product testing segment.

InsituGen monetizes through one-time test kit sales and transaction-based laboratory testing services, with pricing set on a quote basis by volume and customer type. Go-to-market combines an exclusive worldwide distribution partnership with Berlinger Special AG (channel coverage into 175+ countries for firstFlagX in the equine anti-doping segment) with direct enterprise sales for NeuterReady and contract testing. The company is privately held, has between 11 and 50 employees, has raised approximately US$2.5 million in disclosed external capital since 2020 across NZ, US, and European investors, and is actively raising additional capital to support product development and commercial expansion.

InsituGen firmographics

Firmographics
Name
InsituGen
Legal name
InsituGen Limited
Website
https://insitugen.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
InsituGen Limited is a New Zealand biotech that sells cell-free bioassay test kits — firstFlagX for anti-doping laboratories and NeuterReady for companion animal maturity assessment — plus contract testing services, targeting anti-doping labs, veterinary clinics, and supplement manufacturers.
Ownership category
akta.pro rank

InsituGen industry classification

Industry
Product category
Bioassay Diagnostic Test Kits
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Medical and Diagnostic Laboratories (62151)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Services-Testing Laboratories (8734)
akta.pro industry
PRIMARYHLAGADAH
Cell-Based & Potency Assays (Bioassays)
SECONDARYHLAMADAF
Reproductive & Endocrinology Diagnostics (Fertility, Hormones)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Diagnostics (Labs & Imaging)
SECONDARYHLAAAKAG
Analytical Testing & QC Release Services (potency, purity, sterility)

Keywords

  • Cell-free bioassay
  • Steroid hormone testing
  • Anti-doping diagnostics
  • Veterinary hormone assays
  • Androgen bioactivity detection

Where InsituGen is headquartered

Location

Headquarters

HQ city
Cambridge
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

InsituGen business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales

Revenue model

  1. Test Kit Product Sales: Sale of proprietary test kits including firstFlagX and NeuterReady to laboratories, veterinary clinics, and anti-doping facilities. Revenue generated from initial kit purchases with recurring demand from ongoing testing requirements.
  2. Laboratory Testing Services: Contract testing services offered through InsituGen's New Zealand laboratory facility for samples requiring specialized bioactivity analysis. Provides fee-for-service revenue for complex or high-volume testing needs.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goEnterprise/B2B pricing for laboratory test kits

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

InsituGen product offering

Product offering

Core offering

InsituGen develops and sells proprietary cell-free bioassay test kits for detecting androgen and estrogen steroid hormone bioactivity. The company offers the firstFlagX androgen bioactivity test kit for anti-doping laboratories, the NeuterReady veterinary test kit for companion animal hormone assessment, and contract testing services performed at its Dunedin, New Zealand laboratory.

Product overview

InsituGen offers a portfolio of bioassay-based products and services for steroid hormone detection. The core offering centers on cell-free bioassay technology that replicates natural biological signaling pathways of estrogen and androgen receptors. The main products are firstFlagX (an androgen bioactivity test kit for use in reference laboratories), NeuterReady (a veterinary testing service for companion animal maturity assessment), and a laboratory testing service for external customers. firstFlagX and NeuterReady are the two commercial products launched since the company's founding in 2020, with testing services providing additional customer access to the technology.

Differentiator

Problem solved

Functional benefit

Brands

  • firstFlagX: InsituGen's bioassay technology transformed into a ready-to-use kit for the detection of total androgen bioactivity. Used in thoroughbred horse and camel anti-doping laboratories.
  • NeuterReady

Products and services

  • firstFlagX Androgen Bioactivity Test Kit (FFX-1) A ready-to-use 96-well format bioassay kit that detects total androgen bioactivity, including unknown androgens, designer steroids, testosterone-mimics, and any compound that binds to the androgen receptor. Delivers results within 2 hours using standard laboratory fluorometers. Used by reference and anti-doping laboratories.
  • NeuterReady Veterinary testing service and kit for determining optimal timing for neutering/spaying companion animals based on biological maturity assessment through circulating androgen bioactivity, enabling data-driven treatment decisions. Used by veterinary clinics and companion animal owners.
  • Testing Services – Test with Us Non-targeted testing service using InsituGen's cell-free bioassay technology at the New Zealand laboratory, testing human supplements, products, clinical plasma samples, and environmental samples for estrogen and androgen bioactivity.

Quantifiable outcome

  • Results delivered in 2 hours compared to 24-48 hours for traditional cell-based methods
  • +2 more outcomes

Companies that use InsituGen

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

InsituGen technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

InsituGen partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Berlinger Special AGcoreChannel Partner/ Reseller/ DistributorExclusive worldwide distribution partnership for firstFlagX androgen bioactivity test kits to equine anti-doping laboratories. Berlinger Special AG, a specialized provider of anti-doping equipment and services, distributes InsituGen's firstFlagX test kits globally, enabling market access to laboratories in over 175 countries. The partnership leverages Berlinger's established relationships with racing federations and anti-doping authorities.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

InsituGen competitors and assessment

Company assessment

Broad incumbents

  • Agilent Technologies: Major analytical instrument provider (mass spec, chromatography) widely used in anti-doping reference laboratories. Represents the incumbent targeted-detection paradigm that InsituGen's non-targeted bioassay seeks to complement.
  • IDEXX Laboratories: Leading veterinary diagnostics company serving companion animal clinics with in-clinic and reference lab testing. Comparable as a scaled veterinary diagnostics platform into which NeuterReady's hormone maturity test could be distributed.
  • SGS: Global testing, inspection, and certification company with dedicated supplement, food, and environmental contaminant testing services. Comparable as an established contract testing alternative for supplement and environmental bioactivity work.
  • Thermo Fisher Scientific: Global analytical instruments and life sciences leader offering mass spectrometers, immunoassays, and clinical diagnostics that compete with and complement InsituGen's bioassay in anti-doping and clinical endocrinology reference labs.
  • Waters Corporation: Analytical instrument vendor (LC-MS/MS) used in equine and human anti-doping laboratories worldwide. Represents an alternative screening technology stack competing for the same lab budget.
  • Eurofins Scientific: Global testing services conglomerate with extensive anti-doping, supplement, and environmental testing capacity. Comparable as a large-scale service-lab competitor and potential channel partner for InsituGen's test kits.
  • Zoetis: Largest global animal health company with diagnostics and reproductive management products. Closely comparable as the dominant channel and R&D investor in companion animal diagnostics where NeuterReady competes.
  • SCIEX (Danaher): Mass spectrometry platform vendor with deep penetration in anti-doping and clinical endocrinology reference labs. Competes for the same analytical workflow budget that InsituGen's firstFlagX targets.

Direct peers

  • Berlinger Special AG: Swiss anti-doping equipment specialist and exclusive worldwide distributor of InsituGen's firstFlagX kits. Operates in the same equine/human anti-doping laboratory customer segment and supplies complementary sample collection and cold-chain equipment used alongside bioassay testing.
  • Randox Laboratories: Clinical and anti-doping diagnostics company offering biochip immunoassays and evidence-testing kits to sports, forensic, and clinical labs. Comparable as a multi-kit specialty diagnostics provider in anti-doping reference laboratories.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

InsituGen social profiles

Digital presence

InsituGen financial estimates

Financial estimate

Revenue estimate

Valuation estimate

InsituGen leadership team

Management profile

Number of profiles

Profiles10 records

InsituGen funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

InsituGen M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about InsituGen

What does InsituGen do?

InsituGen develops and sells proprietary cell-free bioassay test kits for detecting androgen and estrogen steroid hormone bioactivity. The company offers the firstFlagX androgen bioactivity test kit for anti-doping laboratories, the NeuterReady veterinary test kit for companion animal hormone assessment, and contract testing services performed at its Dunedin, New Zealand laboratory.

Is InsituGen a public or private company?

InsituGen is a private company. It is classified as venture growth investor backed and is currently operating.

When was InsituGen founded?

InsituGen was founded in 2020. It employs 11 to 50 people.

Where is InsituGen based?

InsituGen is headquartered in Cambridge, United Kingdom, in the Europe region.

How does InsituGen make money?

Two revenue lines are on record. Test Kit Product Sales are the primary driver. The others are laboratory Testing Services.

Who are InsituGen's main competitors?

Broad incumbents on record are Agilent Technologies, IDEXX Laboratories, SGS, Thermo Fisher Scientific, Waters Corporation, Eurofins Scientific, Zoetis and SCIEX (Danaher). Direct peers are Berlinger Special AG and Randox Laboratories.

Does InsituGen have an API?

No public API is recorded for InsituGen.

What industry is InsituGen in?

InsituGen's product category is Bioassay Diagnostic Test Kits. Its primary akta.pro industry code is HLAGADAH, Cell-Based & Potency Assays (Bioassays), with a secondary code of HLAMADAF, Reproductive & Endocrinology Diagnostics (Fertility, Hormones). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals